6. Funding and award opportunities
Closing soon
The Bridge Program helps researchers, scientists, clinicians and government professionals to navigate the pharmaceutical research commercialisation pathway. Fully funded, it offers online training modules delivered by QUT, and a seminar and event series that attracts high-profile industry leaders as speakers. Closes 21 Feb 2022.
NHMRC – Investigator Grants 2022 – Minimum data 16 Feb 2022, Closes 16 March 2022.
MRFF – EPCDRI – 2022 Models of Care to Improve the Efficiency and Effectiveness of Acute Care Grant Opportunity – Minimum data 16 Feb 2022, closes 02 March 2022.
MRFF – Emerging Priorities and Consumer Driven Research Initiative– 2021 Chronic Musculoskeletal Conditions in Children and Adolescents Grant Opportunity. Closes 16 Feb 2022.
MRFF – Clinical Trials Activity Initiative – 2021 International Clinical Trial Collaborations Grant Opportunity. Closes 16 Feb 2022.
MRFF – Dementia, Ageing and Aged Care Mission – 2021 Dementia, Ageing and Aged Care Grant Opportunity. Closes 16 Feb 2022.
MRFF – Genomics Health Futures Mission – 2021 Genomics Health Futures Mission Grant Opportunity. Closes 16 Feb 2022.
MRFF Indigenous Health Research Fund – 2021 Indigenous Health Research Grant Opportunity. Closes 16 Feb 2022.
MRFF – PPHRI – 2021 Optimising the Clinical Use of Immunoglobulins Grant Opportunity. Closes 16 Feb 2022.
MRFF – CRR – 2021 COVID-19 Treatment Access and Public Health Activities Grant Opportunity. Closes 23 Feb 2022.
MRFF – Primary Health Care Research Initiative – 2021 Primary Health Care Research Grant Opportunity. Closes 23 Feb 2022.
MRFF Stem Cell Therapies Mission – 2021 Stem Cell Therapies grant opportunity. Closes 23 Feb 2022.
MRFF – Cardiovascular Health Mission – 2021 Cardiovascular Health Grant Opportunity. Closes 23 Feb 2022.
Nominations are now open for the Australian Academy of Health and Medical Sciences’ Medal for Outstanding Female Researcher, closes 27 Feb 2022.
MRFF – Australian Brain Cancer Mission – 2021 GBM AGILE Grant Opportunity. Minimum data 16 Feb, closes 02 March 2022.
MRFF – PPHRI – 2021 Optimising the Clinical Use of Immunoglobulins Grant Opportunity. Minimum data 16 Feb, closes 02 March 2022.
Nominate for the 2022 ACTA Trial of the Year Awards – there are 4 award categories. Closes 06 March 2022.
MRFF – Emerging Priorities and Consumer Driven Research – 2021 Chronic Neurological Conditions Grant Opportunity. Minimum data 23 Feb, closes 09 March 2022.
Expressions of interest open for Australia’s first, $40m MRFF-backed national biotech incubator, CUREator. To be announced in early 2022.
Register with GrantConnect to receive notifications when new opportunities open. |